Assessment of follicle destruction in chemical-induced ovarian toxicity

Annual Review of Pharmacology and Toxicology

Volumn 36, Issue , 1996, Pages 307-331

  Hoyer, Patricia B ^a   Sipes, I Glenn ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

4 vinylcyclohexene; oocyte; ovotoxicity; primordial follicle

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMICAL AGENT; CHLORAMBUCIL; CHLORMETHINE; CYCLOHEXENE DERIVATIVE; CYCLOPHOSPHAMIDE; EPOXIDE; FLUOROURACIL; METHOTREXATE; POLYCYCLIC AROMATIC HYDROCARBON; VINBLASTINE;

ANIMAL MODEL; DRUG TOXICITY; FEMALE; HUMAN; IONIZING RADIATION; METABOLIC ACTIVATION; METABOLITE; NONHUMAN; OCCUPATIONAL EXPOSURE; OOCYTE; OVARY FOLLICLE; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; SPECIES DIFFERENCE; TOXICOKINETICS; XENOBIOTIC METABOLISM;

EID: 0029892634     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pa.36.040196.001515     Document Type: Review

References (122)

1. Richards JS. 1980. Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation. Physiol. Rev. 60:51-89
2. Hedge GA, Colby HD, Goodman RL, eds. 1987. Clinical Endocrine Physiology, pp. 189-222. Philadelphia: Saunders. 1st ed.
3. Hirshfield AN. 1991. Development of follicles in the mammalian ovary. Int. Rev. Cytol. 124:43-101
4. Hirshfield AN. 1991. Theca cells may be present at the onset of follicular growth. Biol. Reprod. 44:1157-62
5. Roy SK, Greenwald GS. 1985. An enzymatic method for dissociation of intact follicles from the hamster ovary: histological and quantitative aspects. Biol. Reprod. 32:203-15
6. Mattison DR, Schulman JD. 1980. How xenobiotic compounds can destroy oocytes. Contemp. Obster. Gynecol. 15(3):157-69
7. Hirshfield AN. 1989. Rescue of atretic follicles in vitro and in vivo. Biol. Reprod. 40:181-90
8. Hirshfield AN, Schmidt WA. 1987. Kinetic aspects of follicular development in the rat. In Regulation of Ovarian and Testicular Function, ed. VB Mahesh, DS Dindsa, pp. 211-36. New York: Plenum
9. Mattison DR. 1985. Clinical manifestations of ovarian toxicity. In Reproductive Toxicology, ed. RL Dixon, pp. 109-30. New York: Raven
10. Thomas JA. 1993. Toxic responses of the reproductive system. In Toxicology, ed. MO Amdur, J Doull, CD Klassen, pp. 484-520. New York: McGraw-Hill
11. Krarup T. 1967. 9:10-Dimethyl-1:2-benozanthracene induced ovarian tumors in mice. Acta Pathol. Microbiol. Scand. 70:241-48
12. Krarup T. 1969. Oocyte destruction and ovarian tumorigenesis after direct application of a chemical carcinogen (9: 10-dimethyl-1:2-benzanthrene) to the mouse ovary. Int. J. Cancer 4:61-75
13. Krarup T. 1970. Oocyte survival in the mouse ovary after treatment with 9,10-1,2-benzanthracene. J. Endocrinol. 46:483-95
14. Krarup T. 1970. Effect of 9:10-dimethyl-1 2-benzanthracene on the mouse ovary. Acta Endocrinol. 64:489-507
15. Mattison DR, West DM, Menard RH. 1979. Differences in benzo(a)pyrene metabolic profile in rat and mouse ovary. Biochem. Pharmacol. 28:2101-4
16. Maronpot RR. 1987. Ovarian toxicity and carcinogenicity in eight recent National Toxicology Program studies. Environ. Health Perspect. 73:125-30
17. Melnick RL, Huff J, Chou BJ, Miller RA. 1990. Carcinogenicity of 1,3-butadiene in C57BL/6 X C3HF1 mice at low exposure concentrations. Cancer Res. 50:6592-99
18. Beamer WG, Tennent BJ. 1986. Gonadotropin uptake in genetic and irradiation models of ovarian tumorigenesis. Biol. Reprod. 34:761-70
19. Tennent BJ, Beamer WG. 1986. Ovarian tumors not induced by irradiation and gonadotropins in hypogonadal (hpg) mice. Biol. Reprod. 34:751-60
20. Bengtsson M, Rydstrom J. 1983. Regulation of carcinogen metabolism in the rat ovary by the estrous cycle and gonadotropin. Science 219:1437-38
21. Mukhtar H, Philpot RM, Bend JB. 1978. The postnatal development of microsomal epoxide hydrase, cytosolic glutathione S-transferase, and mitochondrial and mircrosomal cytochrome P-450 in adrenals and ovaries of female rats. Drug Metab. Dispos. 6:577-83
22. Heinrichs WL, Juchau MR. 1980. Extrahepatic drug metabolism: the gonads. In Extrahepatic Metabolism of Drugs and Other Foreign Compounds, ed. TE Gram, 1:319-22. New York: SP Med. Sci. Books
23. Mattison DR, Thorgeirsson SS. 1979. Ovarian aryl hydrocarbon hydroxylase activity and primordial oocyte toxicity of polycyclic aromatic hydrocarbons in mice. Cancer Res. 39:3471-75
24. Bengtsson M, Reinholt FP, Rydstrom J. 1992. Cellular localization and hormonal regulation of 7,12-dimethylbenz[a]anthracene mono-oxygenase activity in the rat ovary. Toxicology 71:203-22
25. Buccione R, Schroeder AS, Eppig JJ. 1990. Interactions between somatic cells and germ cells throughout mammalian oogenesis. Biol. Reprod 43:543-47
26. Generoso W, Stout SK, Huff SW. 1971. Effects of alkylating chemicals on reproductive capacity of adult female mice. Mutat. Res. 13:171-84
27. Jarrell JF, Bodo L, YoungLai EV, Barr RD, O'Connell GJ 1991. The short-term reproductive toxicity of cylcophosphamide in the female rat. Reprod. Toxicol. 5.481-85
28. Davis BJ, Maronpot RR, Heindel JJ 1994. Di-(2-ethylhexyl)phthalate suppresses estradiol and ovulation in cycling rats. Toxicol. Appl. Pharmacol. 128:216-23
29. Hooser SB, Douds DA, Hoyer PB, Sipes IG. 1994. Long-term ovarian and hormonal alterations due to the ovotoxin, 4-vinylcyclohexene. Reprod. Toxicol. 8:315-23
30. Russell LB, Stelzner KF, Russell WL. 1959. Influence of dose of radiation effect on fertililty in female mice. Proc. Soc. Exp. Biol. Med. 102:471-79
31. Chapman RM. 1983. Gonadal injury resulting from chemotherapy. Am. J. Ind. Med. 4:149-61
32. Warne GL, Fairley KF, Hobbs JB, Martin FIR. 1973. Cyclophosphamide-induced ovarian failure. N. Engl. J. Med. 289:1159-62
33. Dobson RL, Feiton JS. 1983. Female germ cell loss from radiation and chemical exposures. Am. J. Ind. Med. 4:175-90
34. Damewood MD, Grochow LB. 1986. Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil. Steril. 45:443-59
35. Jarrell J, YoungLai EV, Barr R, O'Connell G, Belbeck L, McMahon A. 1986. An analysis of the effects of increasing doses of ionizing radiation to the exteriorized rat ovary on folliuclar development, atresia and serum gonadotropin levels. Am. J. Obstet. Gynecol. 154:306-9
36. Jarrell J, YoungLai EV, McMahon A, Barr R, O'Connell G, Belbeck L. 1987. Effects of ionizing radiation and pretreatment with [D-Leu6,des-Gly10] luteinizing hormone-releasing hormone ethylamide on developing rat ovarian follicles. Cancer Res. 47:5005-8
37. Koyama H, Wada T, Nishizawa Y, Iwanaga T, Aoki Y, et al. 1977. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 39:1403-9
38. Dnistrian AM, Schwartz MK, Fracchia AA, Kaufman RJ, Hakes TB, Curries VE. 1983. Endocrine consequences of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patients. Cancer 51:803-7
39. Sobrinho LG, Levine RA, DeConti RC. 1971. Amenorrhea in patients with Hodgkins disease treated with antineo-plastic agents. Am. J. Obstet. Gynecol. 109:135-39
40. Miller JJ, Williams GF, Leissring JC. 1971. Multiple late complications of therapy with cylcophosphamide, including ovarian destruction. Am. J. Med. 50:530-35
41. Botta JA Jr, Hawkins HC, Weikel JH Jr. 1974. Effects of cyclophosphamide on fertililty and general reproductive performance in rats. Toxicol. Appl. Pharmacol. 27:602-11
42. Ataya KM, Valeriote FA, Ramahi-Ataya AJ. 1989. Effect of cyclophosphamide on immature rat ovary. Cancer Res. 49:1660-64
43. Miller JJ III, Cole LJ. 1970. Changes in mouse ovaries after prolonged treatment with cyclophosphamide. Proc. Soc. Exp. Biol. Med. 133:190-93
44. Plowchalk DR, Mattison DR. 1992. Reproductive toxicity of cyclophosphamide in the C57BL/6N mouse. 1. Effects on ovarian structure and function. Reprod. Toxicol. 6:411-21
45. Shiromizu K, Thorgeirsson SS, Mattison DR. 1984. Effect of cyclophosphamide on oocyte and follicle number in Sprague Dawley rats, C57BL/6N and DBA/2N mice. Pediatr. Pharmacol. 4:213-21
46. Plowchalk DR, Mattison DR. 1991. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide. Toxicol. Appl. Pharmacol. 107:472-81
47. Mattison DR, Thorgeirsson SS. 1978. Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet 1:187-88
48. Vahakangas K, Rajaniemi H, Pelkonen O. 1985. Ovarian toxicity of cigarette smoke exposure during pregnancy in mice. Toxicol. Lett. 25:75-80
49. Jick H, Porter J, Morrison AS. 1977. Relation between smoking and age of natural menopause. Lancet 1:1354-55
50. Mackenzie KM, Angevine DM. 1981. Infertility in mice exposed in utero to benzo(a)pyrene. Biol. Reprod. 24:183-91
51. Basler A, Rohrborn G. 1976. Chromosome aberrations in oocytes of NMR1 mice and bone marrow cells of Chinese hamsters induced with 3,4-benzpyrene. Mutat. Res. 38:327-32
52. Gulyas BJ, Mattison DR. 1979. Degeneration of mouse oocytes in response to polycyclic aromatic hydrocarbons. Anat. Rec. 193:863-82
53. Mattison DR. 1980. Morphology of oocyte and follicle destruction by polycyclic aromatic hydrocarbons in mice. Toxicol. Appl. Pharmacol. 53:249-59
54. Mattison DR. 1979. Difference in sensitivity of rat and mouse primordial oocytes to destruction by polycyclic aromatic hydrocarbons. Chem.-Biol. Interact. 28:133-37
55. Takizawa K, Yagi H, Jerina DM, Mattison DR. 1984. Murine strain diffferences in ovotoxicity following intraovarian injection with benzo(a)pyrene, (+)-(7R,8S)-oxide, (-)-(7R,*R)-dihydrol, or (+)-(7R,8S)-diol-(9S,10R)-epoxide-2. Cancer Res. 44:2571-76
56. Mattison DR. 1983. Oocyte destruction by polycyclic aromatic hydrocarbons. Am. J. Ind. Med. 4:191-202
57. Shiromizu K, Mattison DR. 1984. The effect of intraovarian injection of benzo(a)pyrene on primordial oocyte number and ovarian aryl hydrocarbon [benzo(a)pyrene] hydroxylase activity. Toxicol. Appl. Pharmacol. 76:18-25
58. Mattison DR, Thorgeirsson SS. 1977. Genetic differences in mouse ovarian metabolism of benzo(a)pyrene and oocyte toxicity. Biochem. Pharmacol. 26:909-12
59. Mattison DR, Thorgeirsson SS. 1978. Gonadal aryl hydrocarbon hydrolase in rats and mice. Cancer Res. 38:1368-73
60. Mattison DR, Nightingale MR. 1980. The biochemical and genetic characteristics of murine ovarian aryl hydrocarbon (benzo(a)pyrene)hydroxylase activity and its relationship to primordial oocyte destruction by polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 56:399-408
61. Bengtsson M, Montelius J, Mankowitz L, Rydstrom J. 1983. Metabolism of polycyclic aromatic hydrocarbons in the rat ovary. Biochem. Pharmacol. 32:129-36
62. Bengtsson M, Dong Y, Mattison DR, Rydstrom J. 1987. Mechanisms of regulation of rat ovarian 7,12-dimethylbenz[a]anthracene hydroxylase. Chem.-Biol. Interact. 63:15-27
63. Bengtsson M, Mattison DR. 1989. Gonadotropin-dependent metabolism of 7,12-dimethylbenz(a)anthracene in the ovary of rhesus monkey. Biochem Pharmacol. 38:1869-72
64. Bengtsson M, Hamberger L, Rydstrom J. 1988. Metabolism of 7,12-diemthylbenz(a)anthracene by different types of cells in the human ovary. Xenobiotica 18:1255-70
65. Kari FW, Huff JE, Leininger J, Haseman JK, Eustis SL. 1989. Toxicity and carcinogenicity of nitrofurazone in F344/N rats and B6C3F1 mice. Food Chem. Toxicol. 27:129-37
66. Hemminki K, Falck K, Vainio H. 1980. Comparison of alkylation rates and mutagenicity of directly acting industrial and laboratory chemicals. Arch. Toxicol. 46:277-85
67. Huff JE, Melnick RL, Solleveld HA, Haseman JK, Powers M, Miller RA. 1984. Mulitple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science 227:548-49
68. Miller RA, Boorman GA. 1990. Morphology of neoplastic lesions induced by 1,3 butadiene in B6C3F1 mice. Environ. Health Perspect. 86:37-48
69. Melnick RL, Huff JE, Bird MG, Acquavella JF. 1990. Symposium overview: toxicology, carcinogenesis, and human health aspects of 1,3 butadiene. Environ. Health Perspect. 86:3-5
70. Tennant RW. 1991. The genetic toxicity database of the National Toxicology Program, evaluation of the relationship between genetic toxicity and carcinogenesis. Environ. Health Perspect. 96:47-51
71. Mehlman MA, Legator MS. 1991. Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industry. Part II: Carcinogeniciy mutagenicity and developmental toxicity of 1,3-butadiene. Toxicol. Ind. Health 7:207-20
72. Chhabra RS, Huff J, Haseman J, Jokinen MP, Hetjmancek M. 1990. Dermal toxicity and carcinogenicity of 4-vinyl-1-cyclohexene diepoxide in Fischer rats and B6C3F1 mice. Fund. Appl. Toxicol. 14:752-63
73. Collins JJ, Montali RJ, Manus AG. 1987. Toxicological evaluation of 4-vinylcyclohexene. II. Induction of ovarian tumors in female B6C3F1 mice by chronic oral administration of 4-vinylcyclohexene. J. Toxicol. Environ. Health 21:507-24
74. National Toxicology Program (NTP). 1986. Toxicology and carinogenesis studies of 4-vinylcyclohexene in F344/N rats and B6C3F1 mice. NTP Tech. Rep. No. 303. US Dep. Health Hum. Serv Public Health Serv. Natl. Inst. Health. Public Inf. Natl. Toxicol. Program, Research Triangle Park, NC
75. National Toxicology Program (NTP). 1989. Toxicology and carcinogenesis studies of 4-vinyl-1-cyclohexene diepoxide in F344/N rats and B6C3F1 mice. NTP Tech. Rep. No. 362. US Dep. Health Hum. Serv. Public Health Serv. Natl. Inst. Health. Public Inf. Natl. Toxicol. Program, Research Triangle Park, NC
76. Chhabra RS, Elwell MR, Peters A. 1990 Toxicity of 4-vinyl-1-cylcohexene diepoxide after 13 weeks of dermal or oral exposure in rats and mice. Fund. Appl. Toxicol. 14:745-51
77. Collins JJ, Manus AG. 1987. Toxicological evaluation of 4-vinylcyclohexene. I. Prechronic (14 day) and subchronic (13 week) gavage studies in Fischer 344 rats and B6C3F1 mice. J. Toxicol. Environ. Health 21:493-505
78. Smith BJ, Mattison DR, Sipes IG. 1990. The role of epoxidation in 4-vinylcyclohexene-induced ovarian toxicity. Toxicol. Appl. Pharmacol. 105:372-81
79. Murray MP, Cummins JE. 1979. Mutagenic activity of epoxy embedding reagents employed in electron microscopy. Environ. Mutagen 1:307-13
80. deMeester C, Poncelet F, Roberfroid M, Mercier M. 1978. Mutagenicity of butadiene monoepoxide. Biochem. Biophys. Res. Commun. 80:298-305
81. Wade MJ, Moyer JW, Hine CH. 1979. Mutagenic action of a series of epoxides. Mutat. Res. 66:367-71
82. Simmon VF, Baden JM. 1980. Mutagenic activity of vinyl compounds and derived epoxides. Mutat. Res. 78:227-31
83. El-Tantawy MA, Hammock BD. 1980. The effect of hepatic microsomal and cytosolic subcellular fractions on the mutagenic activity of epoxide-containing compounds in the Salmonella assay. Mutat. Res. 79:59-71
84. Voogd CE, VanderStel JJ, Jacobs JJJAA. 1981. The mutagenic action of aliphatic epoxides. Mutat. Res. 89:269-82
85. Frantz SW, Sinsheimer JE. 1981. Bacterial mutagenicity and toxicity of cycloaliphatic epoxides. Mutat. Res. 90:67-78
86. Turchi G, Bonatti S, Citti L, Gervasi PG, Abbondandolo A. 1981. Alkylating properties and genetic activity of 4-vinylcyclohexene metabolites and structurally related epoxides. Mutat. Res. 83:419-30
87. Gervasi PG, Citti L, DelMonte M, Longo V, Benetti D. 1985. Mutagenicity and chemical reactivity of epoxide intermediates of the isoprene metabolism and other structurally related compounds. Mutat. Res. 156:77-82
88. Watabe T, Hiratsuka A, Isobe M, Ozawa N. 1980. Metabolism of d-limonene by hepatic microsomes to non-mutagenic epoxides toward Salmonella typhimurium. Biochem. Pharmacol. 29:1068-71
89. Jung R, Ceermann D, Glatt HR, Oesch F. 1981 Mutagenicity of structurally related oxirane derivatives of benzene and its hydrogenated congeners. Mutat. Res. 81:11-19
90. deMeester C, Poncelet F, Roberfroid M, Mercier M. 1980. The mutagenicity of butadiene towards Salmonella typhimurium. Toxicol. Lett. 6:125-30
91. Tennent RW. 1991. The genetic toxicity database of the National Toxicology Program: evaluation of the relationship between genetic toxicity and carcinogenicity. Environ. Health Perspect. 86:37-48
92. Citti L, Gervasi PG, Turchi G, Bellucci G, Bianchini R. 1984. The reaction of 3,4-epoxy-1-butene with deoxyguanosine and DNA in vitro: synthesis and characterization of the main adducts. Carcinogenesis 5:47-52
93. deRaat WK. 1978. Induction of sister chromatid exchanges by styrene and its presumed metabolite styrene oxide in the presence of rat liver homogenate. Chem.-Biol. Interact. 20:163-70
94. 14C-styrene oxide) in the rabbit. Biochem. Pharmacol. 25:187-93
95. Lee IP, Suzuki K, Mukhtar H, Bend JR. 1980. Hormonal regulation of cytochrome P-450-dependent monoxygenase activity and epoxide-metabolizing enzyme activities in testis of hypophysectomized rats. Cancer Res. 40:2486-92
96. Mukhtar H, Philpot RM, Bend JR. 1978. Metabolizing enzyme activities and cytochrome P-450 content of rat ovaries during pregnancy. Biochem. Biophys. Res. Commun. 81:89-98
97. Mukhtar H, Lee IP, Foureman GL, Bend JB. 1978. Epoxide metabolizing enzyme activities in rat testes: postnatal development and relative activity in interstitial and spermatogenic cell compartments. Chem.-Biol. Interact. 22:153-65
98. Filser JG, Bolt HM. 1984. Inhalation pharmacokinetics based on gas uptake studies. VI. Comparative evaluation of ethylene oxide and butadiene monoxide as exhaled reactive metabolites of ethylene and 1,3-butadiene in rats. Arch Toxicol. 55:219-23
99. Bolt HM, Schmiedel G, Filser JG, Rolzhauser HP, Lieser K, et al. 1983. Biological activation of 1,3-butadiene to vinyl oxirane by rat liver microsomes and expiration of the reactive metabolite by exposed rats. J. Cancer Res. Clin. Oncol. 106:112-16
100. Elfarra AA, Duescher RJ, Pesch CM. 1991. Mechanisms of 1,3-butadiene oxidations to butadiene monoxide and crotonaldehyde by mouse liver microsomes and choloperoxidase. Arch. Biochem. Biophys. 286:244-51
101. Smith BJ, Mattison DR, Sipes IG. 1990. Hepatic bioactivation of 4-vinylcyclohexene to ovotoxic epoxides. In Biological Reactive Intermediates IV, ed. CM Witmer, pp. 465-70. New York: Plenum
102. Smith BJ, Carter DE, Sipes IG. 1990. Comparison of the disposition and in vitro metabolism of 4-vinylcyclohexene in the female mouse and rat. Toxicol. Appl. Pharmacol. 105:364-71
103. Murphy ED, Beamer WG. 1973. Plasma gonadotropin levels during early stages of ovarian tumorigenesis in mice of the WxAVv genotype. Cancer Res. 33:721-23
104. Nishizuka Y, Sakakura T, Taguchi O. 1976. Mechanism of ovarian tumorigenesis in mice after neonatal thymectomy. Natl. Cancer Inst. Monogr. 51:89-96
105. Rappaport SM, Fraser DA. 1977 Air sampling and analysis in rubber vulcanization area. Am. Ind. Hyg. Assoc. J. 38:205-9
106. Flaws JA, Doerr JK, Sipes IG, Hoyer PB. 1994. Destruction of pre-antral follicles Ln adult rats by 4-vinylcyclohexene diepoxide. Reprod. Toxicol. 8:509-14
107. Smith BJ, Sipes IG, Stevens JC, Halpert JR. 1990. The biochemical basis for the species difference in hepatic microsomal 4-vinylcyclohexene epoxidation between female mice and rats. Carcinogenesis 11:1951-57
108. Hooser SB, Parola LR, Van Ert MD, Sipes IG. 1993. Differential ovotoxicity of 4-vinylcyclohexene and its analog, 4-phenycyclohexene. Toxicol. Appl. Pharmacol. 119:302-5
109. Doerr JK, Hooser SB, Smith BJ, Sipes IG. 1995. Ovarian toxicity of 4-vinylcyclohexene and related olefins in B6C3F1 mice: Role of diepoxides. Chem. Res. Toxicol. 8:963-69
110. Giannarini C, Citti L, Gervasi PG, Turchi G. 1981. Effects of 4-vinylcyclohexene and its main oxirane metabolite on mouse hepatic microsomal enzymes and glutathione levels. Toxicol. Lett. 8:115-21
111. Salyers KL, Zheng W, Sipes IG. 1993. Metabolism and toxicokinetics of 4-vinyl-1-cyclohexene diepoxide in female F-344 rats. Toxciologist 13.175 (Abstr.)
112. Casanady GA, Guengerich FP, Bond JA. 1992. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 13:1143-53
113. Flaws JA, Salyers KL, Sipes IG, Hoyer PB. 1994. Reduced ability of rat pre-antral ovarian follicles to metabolize 4-vinyl-1-cyclohexene diepoxide in vitro. Toxicol. Appl. Pharmacol. 126:286-94
114. Flaws JA, Springer LN, Sipes IG, Hoyer PB. 1994. 4-Vinylcyclohexene diepoxide (VCD) inhibits protein synthesis in rat small pre-antral follicles. Biol. Reprod. 50(Suppl. 1):185 (Abstr.)
115. Springer LN, Tilly JL, Sipes IG, Hoyer PB. 1995. Effect of 4-vinylcyclohexene diepoxide on DNA integrity in rat small pre-antral ovarian follicles. Toxicologist 15:1344
116. Springer LN, McAsey M, Sipes IG, Hoyer PB. 1995. Induction of cell death in small pre-antral rat follicles by dosing with 4-vinylcyclohexene diepoxide. Biol. Reprod. 52 (Suppl. 1):371
117. Kerr JFR, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26:239-357
118. Collins RJ, Harmon BV, Gobe GC, Kerr JFR. 1992. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol. 61:451-53
119. Cohen JJ. 1993. Apoptosis. Immunol. Today 14:126-30
120. Hooser SB, DeMerell DG, Douds DA, Hoyer PB, Sipes IG. 1995. Testicular germ cell toxicity caused by vinylcyclohexene diepoxide in male mice. Reprod. Toxicol. 9:359-67
121. Grizzle TB, George JD, Fail PA, Seely JC, Heindel JJ. 1994. Reproductive effects of 4-vinylcyclohexene in Swiss mice assessed by a continuous breeding protocol. Fund. Appl. Toxicol. 22:122-29
122. Hoyer PB, Hooser SB, Sipes IG. 1994. Teratogenic effects including oocyte destruction caused by exposure to 4-vinylcyclohexene. Toxicologist 14:586 (Abstr.)